| Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. | |
| | |
MedLine Citation:
|
PMID: 20485694 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Canadians with hypertension are recommended to use home blood pressure monitoring (HBPM) on a regular basis. OBJECTIVES: To characterize the use of HBPM among Canadian adults with hypertension. METHODS: Respondents to the 2009 Survey on Living with Chronic Diseases in Canada who reported diagnosis of hypertension by a health professional (n=6142) were asked about blood pressure monitoring practices, sociodemographic characteristics, management of hypertension and blood pressure control. RESULTS: Among Canadian adults with hypertension, 45.9% (95% CI 43.5% to 48.3%) monitor their own blood pressure at home, 29.7% (95% CI 41.1% to 46.3%) receive health professional instruction and 35.9% (95% CI 33.5% to 38.4%) share the results with their health professional. However, fewer than one in six Canadian adults diagnosed with hypertension monitor their own blood pressure at home regularly, with health professional instruction, and communicate results to a health professional. Regular HBPM was more likely among older adults (45 years of age and older); individuals who believed they had a plan for how to control their blood pressure; and those who had been shown how to perform HBPM by a health professional - with the latter factor most strongly associated with regular HBPM (prevalence rate ratio 2.8; 95% CI 2.4 to 3.4). CONCLUSIONS: Although many Canadians with hypertension measure their blood pressure between health care professional visits, a minority do so according to current recommendations. More effective knowledge translation strategies are required to support self-management of hypertension through home measurement of blood pressure. |
| | |
Authors:
|
Christina M Bancej; Norm Campbell; Donald W McKay; Marianne Nichol; Robin L Walker; Janusz Kaczorowski |
Related Documents
:
|
12451814 - Transponder system for non-invasive measurement of intravascular pressure. 21776034 - Association of the catechol-o-methyl transferase gene val158met polymorphism with blood... 20032814 - Altered cardiovascular rhythmicity in children with white coat and ambulatory hypertens... 15565174 - Evaluation of the a&d ua-767 and welch allyn spot vital signs noninvasive blood pressur... 2082064 - Effect of transpupillary argon laser cyclophotocoagulation on anterior chamber oxygen t... 1709634 - Changes of lung surfactant and pressure-volume curve in bleomycin-induced pulmonary fib... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: 26 ISSN: 1916-7075 ISO Abbreviation: Can J Cardiol Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-20 Completed Date: 2010-06-07 Revised Date: 2011-07-28 |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: Canada |
Other Details:
|
Languages: eng Pagination: e152-7 Citation Subset: IM |
Affiliation:
|
Public Health Agency of Canada, Ottawa, Ontario. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Age Factors Aged Aged, 80 and over Antihypertensive Agents / therapeutic use Blood Pressure Determination / methods Blood Pressure Monitoring, Ambulatory / methods, statistics & numerical data* Canada Chronic Disease Confidence Intervals Cross-Sectional Studies Female Follow-Up Studies Humans Hypertension / diagnosis*, drug therapy, epidemiology* Linear Models Male Middle Aged Patient Compliance / statistics & numerical data* Patient Education as Topic* Probability Questionnaires Risk Factors Severity of Illness Index Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hypertension: are you and your patients up to date?
Next Document: Identification of factors driving differences in cost effectiveness of first-line pharmacological th...